SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Outsourcing market’s recently IPO'd stock prices see early spike

Between May 2013, when Quintiles went public , and this week, newly public companies’ stocks in the biopharma outsourcing space have all seen their prices rise by more than 35%.

Academics urge updating WHO, ICH guidelines to ensure quality drugs used in clinical trials

The use of substandard and falsified drugs in clinical trials has been neglected and new information on product quality should be included in the GCP (good clinical practice) guidelines from the WHO and ICH, academics contend in the British Medical Journal .

Japanese companies acquire CMO KBI Biopharma

Tokyo-based CMIC Holdings Co., Innovation Network Corporation of Japan (INCJ), and JSR have agreed to acquire KBI Biopharma, a contract development and manufacturing organization with facilities in Durham and Research Triangle Park, North Carolina and Boulder, Colorado. 

Icon posts solid quarterly results, sees stock rise 10%

Dublin-based CRO Icon saw its quarterly net revenue, backlog and income rise over the same quarter last year, all of which helped to boost its stock by about 10% on Wednesday.

News in brief

Bayer manufactures for biologics start-up in CoLaborator project

Bayer has announced a strategic alliance to manufacture a preclinical candidate for small biotech Aronora.

People on the Move

Contract research: this week's movers

People on the move at Quintiles, preclinical experts and safety consultancies.

INC sees strong quarterly book-to-bill, more diverse customer base

Following its recent IPO , INC Research delivered double-digit net service revenue growth for the year and further diversified its customer base.

Sagent shifts production in-house after US FDA concerns about CMO Emcure

Problems at Emcure Pharmaceutical have prompted US customer Sagent Pharmaceuticals to recall two lots of a muscle relaxant made by the CMO and take production in-house.

Spotlight

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision...

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

One quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with...

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move...

HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergen

HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergen

New hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in...

Strong USD to hit revenues but strategic CROs may see lower costs

Strong US Dollar to hit revenues but strategic CROs may see lower costs

The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals...

Biosimulation – the next step in PK modelling embraced by regulators

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...